NCT05419011 2026-04-13
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
7 trialsNCT05411718 2025-11-13
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04920149 2024-12-17
MesaCAPP
Karolinska University Hospital
Phase 2 Recruiting
NCT03631641 2024-07-01
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
Ohio State University Comprehensive Cancer Center
Phase 2 Terminated
NCT03831698 2023-06-01
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
University of Kansas Medical Center
Phase 2 Unknown
NCT03070574 2019-04-18
MesaCAPP
Medical University of Vienna
Phase 2 Terminated
NCT00224601 2011-02-18
CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed